Andrology & Gynecology: Current ResearchISSN: 2327-4360

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article, Androl Gynecol Curr Res Vol: 1 Issue: 2

Breast Cancer Related Lymphedema: A Review of Recent Developments

Chirag Shah1, Shahed Badiyan1, Shariq Khwaja1, Pawel Dyk1, Douglas Arthur2, Brian Lawenda3, Steven Finkelstein4 and Frank Vicini5*
1Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri, USA
2Department of Radiation Oncology, Virginia Commonwealth University, Virginia, USA
321st Century Oncology, Las Vegas, Nevada, USA
421st Century Oncology, Scottsdale, Arizona, USA
5Michigan Healthcare Professionals/21st Century Oncology, Farmington Hills, Michigan, USA
Corresponding author : Frank A. Vicini, MD, FACR
Michigan Health Care Professionals/21st Century Oncology, 28595 Orchard Lake Rd, Farmington Hills, Michigan 48334, USA
Tel: 248-994-0632; Fax: 248-553-7674; E-mail: [email protected]
Received: January 02, 2013 Accepted: March 19, 2013 Published: March 25, 2013
Citation: Shah C, Badiyan S, Khwaja S, Dyk P, Arthur D, et al. (2013) Breast Cancer Related Lymphedema: A Review of Recent Developments. Androl Gynecol: Curr Res 1:2. doi:10.4172/2327-4360.1000102

Abstract

Breast Cancer Related Lymphedema: A Review of Recent Developments

With improved methods of detection and advancing treatment paradigms, breast cancer outcomes continue to improve. Along with this improved survivorship, an increased focus on long term sequelae of treatment must occur. Breast cancer related lymphedema (BCRL) represents one of the most frequently recognized complications following breast cancer treatment and has been found to be associated with the extent of locoregional therapy. With regards to incidence rates, several randomized trials have found that with utilization of less aggressive axillary staging (i.e., sentinel lymph node biopsies), that rates of BCRL are reduced compared with axillary lymph node dissections.

Keywords:

Track Your Manuscript

Share This Page

Associations